RA
Rapport Therapeutics, Inc. Common Stock (RAPP)
NASDAQ·Healthcare·Biotechnology
$41.56
+1.89%
Mkt Cap $2.05B
Analyst Ratings
Buy
6
Hold
0
Sell
0
Price Target (11 analysts)
$56.40
Range $43.00 – $66.00
Implied Upside
+35.7%
Consensus $56.40 vs current $41.56